Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of oncology, metabolic, autoimmune, neurologic, and infectious diseases in the People's Republic of China. The company offers JS001, a recombinant humanized anti-PD-1 monoclonal antibody under the trade name of TUOYI for the indication of melanoma, mucosal melanoma, soft tissue sarcoma, nasopharyngeal carcinoma, urothelial carcinoma, non-small cell lung carcinoma, triple negative breast carcinoma, esophageal squamous cell carcinoma, and hepatocellular carcinoma. It is also developing UBP1211, a biosimilar of Humira for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriasis; JS002, a recombinant humanized anti-PCSK9 monoclonal antibody for treating hyperlipidemia; UBP1213, a recombinant humanized anti-BLyS monoclonal antibody for injection. In addition, the company is developing JS501, a biosimilar of Avastin; and JS003, a recombinant humanized anti-PD-L1 monoclonal antibody for injection; JS101, a pan-CDK inhibitor; TAB004/JS004, a recombinant humanized anti-BTLA monoclonal antibody for injection; and JS005, a recombinant humanized anti-IL-17A monoclonal antibody for injection. It has an agreement with Eli Lilly and Company to co-develop therapeutic antibodies for the potential prevention and treatment of COVID-19, the disease caused by the SARS-CoV-2 novel coronavirus as well as Coherus Biosciences, Inc. for the development and commercialization of toripalimab, Junshi Biosciences' anti-PD-1 antibody. Shanghai Junshi Biosciences Co., Ltd. was founded in 2012 and is headquartered in Shanghai, People's Republic of China.

Ms. Lu  Yuan

Assistant to GM & Chief of Internal Audit Department

Dr. Jianjun  Zou M.D., Ph.D.

GM, Chief Executive Officer & Executive Director

Dr. Ning  Li

Executive Vice-Chairman of the Board

Dr. Sheng  Yao Ph.D.

Senior Vice President & Executive Director

Dr. Gang  Wang

Deputy GM, Chief Quality Officer, Senior Vice President of Industry Affairs & Executive Director

Pavadinimas	Pavadinimas
Ms. Lu Yuan	Assistant to GM & Chief of Internal Audit Department
Dr. Jianjun Zou M.D., Ph.D.	GM, Chief Executive Officer & Executive Director
Dr. Ning Li	Executive Vice-Chairman of the Board
Dr. Sheng Yao Ph.D.	Senior Vice President & Executive Director
Dr. Gang Wang	Deputy GM, Chief Quality Officer, Senior Vice President of Industry Affairs & Executive Director
Mr. Qian Wei	Chief Commercial Officer
Mr. Jun Xiong	Executive Chairman
Mr. Cong Li	Co-Chief Executive Officer & Executive Director
Mr. Baohong Xu	Financial Director
Mr. Zhuobing Zhang	Deputy GM & Executive Director

Shanghai Junshi Biosciences Co., Ltd.

Shanghai Junshi Biosciences Co., Ltd. Valdymo struktūra

Informacija apie vadovybę